These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15340327)

  • 21. [Effects of a superselective beta1-adrenoblocker nebivolol on the course of coronary heart disease and insulin resistance in patients with diabetes mellitus type 2 after coronary artery bypass grafting].
    Tepliakov AT; Kuznetsova AV; Lukinov AV; Levshin AV
    Ter Arkh; 2007; 79(12):38-43. PubMed ID: 18220029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of insulin-glucose infusion on mortality following acute myocardial infarction in patients with diabetes: the diabetes and insulin-glucose infusion in acute myocardial infarction studies.
    Malmberg K; Rydén L
    Semin Thorac Cardiovasc Surg; 2006; 18(4):326-9. PubMed ID: 17395029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
    Wiviott SD; Braunwald E; Angiolillo DJ; Meisel S; Dalby AJ; Verheugt FW; Goodman SG; Corbalan R; Purdy DA; Murphy SA; McCabe CH; Antman EM;
    Circulation; 2008 Oct; 118(16):1626-36. PubMed ID: 18757948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Off-pump CABG in diabetic patients: does insulin dependency matter?
    Nurozler F; Kutlu T; Küçük G
    Scand Cardiovasc J; 2007 Jan; 41(1):39-43. PubMed ID: 17365976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes.
    Alserius T; Hammar N; Nordqvist T; Ivert T
    Am Heart J; 2006 Sep; 152(3):599-605. PubMed ID: 16923437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy.
    Schmeltz LR; DeSantis AJ; Thiyagarajan V; Schmidt K; O'Shea-Mahler E; Johnson D; Henske J; McCarthy PM; Gleason TG; McGee EC; Molitch ME
    Diabetes Care; 2007 Apr; 30(4):823-8. PubMed ID: 17229943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-operative carbohydrate loading may be used in type 2 diabetes patients.
    Gustafsson UO; Nygren J; Thorell A; Soop M; Hellström PM; Ljungqvist O; Hagström-Toft E
    Acta Anaesthesiol Scand; 2008 Aug; 52(7):946-51. PubMed ID: 18331374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [High blood glucose in diabetics a risk factor in acute myocardial infarction. Intensive insulin therapy--an interesting but not functioning idea].
    Dellborg M; Svensson AM
    Lakartidningen; 2006 Sep 13-19; 103(37):2624-5. PubMed ID: 17022181
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V Pilot Study).
    Schouten O; van Kuijk JP; Flu WJ; Winkel TA; Welten GM; Boersma E; Verhagen HJ; Bax JJ; Poldermans D;
    Am J Cardiol; 2009 Apr; 103(7):897-901. PubMed ID: 19327412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral hypoglycemics: increased postoperative mortality in coronary risk patients.
    Jeger RV; Seeberger MD; Keller U; Pfisterer ME; Filipovic M
    Cardiology; 2007; 107(4):296-301. PubMed ID: 17264509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous glucose-insulin-potassium during off-pump coronary artery bypass surgery does not reduce myocardial injury.
    Shim YH; Kweon TD; Lee JH; Nam SB; Kwak YL
    Acta Anaesthesiol Scand; 2006 Sep; 50(8):954-61. PubMed ID: 16923090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].
    Gustafsson I; Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt PR; MacLeod K; Laakso M; Torp-Pedersen CT; Waldenström A;
    Ugeskr Laeger; 2006 Feb; 168(6):581-4. PubMed ID: 16476220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
    J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic impact of screening for myocardial ischemia among asymptomatic type 2 diabetic subjects].
    Wallemacq CM; Scheen AJ
    Rev Med Suisse; 2008 Aug; 4(168):1800-4. PubMed ID: 18814763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences.
    Newton CA; Raskin P
    Arch Intern Med; 2004 Sep; 164(17):1925-31. PubMed ID: 15451769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Glycemic control in the coronary care unit: prognostic value and new therapeutic strategies].
    Madonna R; Colella ME; De Caterina R
    G Ital Cardiol (Rome); 2008 Sep; 9(9):603-14. PubMed ID: 18783081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diabetes and ischemic heart disease: specific treatment].
    Raddino R; Bonadei I; Teli M; Robba D; Caretta G; Madureri A; Zanini G; Pedrinazzi C; Vizzardi E; Cas LD
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):52S-55S. PubMed ID: 19195307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration.
    Worthley MI; Holmes AS; Willoughby SR; Kucia AM; Heresztyn T; Stewart S; Chirkov YY; Zeitz CJ; Horowitz JD
    J Am Coll Cardiol; 2007 Jan; 49(3):304-10. PubMed ID: 17239711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modern approaches to the problem of comprehensive training of patients with ischemic heart disease combined with type 2 diabetes mellitus which undergo interventional coronary intervention (literature review)].
    Shklovskiĭ BL; Oĭnotkinova OSh; Serebrennikov VN; Baksheev VI
    Voen Med Zh; 2012 Nov; 333(11):33-9. PubMed ID: 23301289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: comparison between patients receiving sulfonylureas and insulin.
    Tentolouris N; Matsagura M; Psallas M; Chatzizacharias A; Fotia M; Arvanitis M; Katsilambros N
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):298-301. PubMed ID: 15926117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.